UTHR UNITED THERAPEUTICS margins

Relative Growth: Rel. Growth: 74

Relative Strength: Rel. Strength: 78

Relative Valuation: Rel. Valuation: 39

Relative Profitability: Rel. Profitability: 93

Gross margin

86.3%

Operating margin

41.4%

EBITDA margin

50.7%

Net margin

38.6%

For the latest period, UNITED THERAPEUTICS has a gross margin of 86.3%, an operating margin of 41.4%, an EBITDA margin of 50.7%, and a net margin of 38.6%. Operating margin had the largest decline, falling by 6.3 percentage points, while the other available margins also weakened.

UTHR margin history

Gross, operating, EBITDA and net margin trends

UNITED THERAPEUTICS's margins averaged 88.18% gross, 46.95% operating, 56.27% EBITDA, and 40.93% net during the last 3 years. The current gross, operating, EBITDA, and net margins are each below their three-year averages.

UTHR margin expansion

Year-over-year margin changes in percentage points

Operating margin led the decline, falling by 6.3 percentage points, while the other available margins also decreased.

Gross margin expansion

-2.3pp

Operating margin expansion

-6.3pp

EBITDA margin expansion

-6pp

Net margin expansion

-2.1pp

UTHR Gross margin

Over the last 3 years, UNITED THERAPEUTICS had an average gross margin of 88.18%. UNITED THERAPEUTICS currently reports a gross margin of 86.3%, 1.9 percentage points below its three-year average. Looking back over the last 3 years, UNITED THERAPEUTICS's gross margin reached 89.2% at its highest point in Dec 2024 and 86.1% at its lowest in Jun 2026.

UTHR Operating margin

Over the last 3 years, the average operating margin for UNITED THERAPEUTICS was 46.95%. Currently, UNITED THERAPEUTICS's current operating margin is 41.4%, which is 5.6 percentage points below its three-year average. UNITED THERAPEUTICS's operating margin ranged from a low of 41.4% in Sep 2026 to a high of 50.9% in Dec 2023.

UTHR EBITDA margin

The average EBITDA margin for UNITED THERAPEUTICS was 56.27% during the last 3 years. As of the latest period, the current EBITDA margin for UNITED THERAPEUTICS is 50.7%, 5.6 percentage points below its three-year average. The EBITDA margin for UNITED THERAPEUTICS moved between 50.7% in Sep 2026 and 59.8% in Mar 2024.

UTHR Net margin

The average net margin for UNITED THERAPEUTICS was 40.93% over the last 3 years. At present, the current net margin for UNITED THERAPEUTICS is 38.6%, 2.3 percentage points below its three-year average. The net margin for UNITED THERAPEUTICS moved between 38.6% in Sep 2026 and 42.3% in Dec 2023.

UTHR margin group comparison

Margins compared with peer-group, industry and sector averages

With a gross margin of 86.3%, UTHR stands higher than the Healthcare sector and its peers average but lower than the industry average. Looking at the Healthcare sector average of 68.3%, UNITED THERAPEUTICS's gross margin is 26% higher.

UTHR margin peer comparison

Compare margins with selected peers

Frequently asked questions

What is UNITED THERAPEUTICS's gross margin?

For the period ending Sep 30, 2026, UTHR recorded a gross margin of 86.3%.

What is UNITED THERAPEUTICS's operating margin?

The current operating margin for UTHR is 41.4% as of Sep 30, 2026.

What is UNITED THERAPEUTICS's EBITDA margin?

The current EBITDA margin for UTHR is 50.7% as of Sep 30, 2026.

What is UNITED THERAPEUTICS's net margin?

The current net margin for UTHR is 38.6% as of Sep 30, 2026.

What are the average margins of UTHR?

Looking back over 3 years, UTHR recorded average margins of 88.2% gross, 47.0% operating, 56.3% EBITDA, and 40.9% net.

What are the highest historical margins of UTHR?

Looking back across 5 years, UTHR reached 93.4% gross in Jun 2022, 52.4% operating in Sep 2022, 59.8% EBITDA in Mar 2024, and 42.3% net in Dec 2023.

What are the lowest historical margins of UTHR?

Looking back across 5 years, UTHR reached its lowest margins at 86.1% gross in Jun 2026, 33% operating in Dec 2021, 39.3% EBITDA in Dec 2021, and 28.2% net in Dec 2021.